Is AVPT a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for AvePoint (AVPT) rests on Durable ARR growth toward a $1B target: AvePoint has posted many consecutive quarters of double-digit organic net-new ARR growth, reaching roughly $435 million of ARR in Q1 2026 (up ~26%). The bear case rests on avePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into. Analysts covering it publish targets from $12.00 to $26.00 against a $12.97 price, so even the professionals disagree by 86% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

AvePoint, Inc. (NASDAQ: AVPT) is a data-management and governance software company headquartered in Jersey City, New Jersey, that sells a cloud-native platform (now marketed as the AvePoint Confidence Platform) to help organizations secure, back up, migrate, and govern their data across third-party SaaS ecosystems including Microsoft 365, Microsoft Teams, Google Workspace, Salesforce, Box, Dropbox, and AWS. Its products span backup and recovery, data migration, information lifecycle and records management, and governance and security controls, sold mostly on a recurring subscription (SaaS) basis to enterprises, government agencies, and increasingly to small and mid-sized businesses through a large channel-partner network. The company went public in 2021 via a SPAC merger with Apex Technology Acquisition Corp and is led by co-founder and CEO Dr. Tianyi Jiang. The investment picture is that of a scaled but still-growing software vendor transitioning from a growth-at-all-costs profile to profitable growth. In the first quarter of 2026 AvePoint reported revenue of about $117 million (up ~26% year over year), SaaS revenue up ~35%, and annual recurring revenue of roughly $435 million (up ~26%), with a dollar-based net retention rate around 111% and non-GAAP operating margin of about 17.5%. The company reached GAAP profitability in 2025 and carries a debt-free balance sheet with a meaningful cash cushion. Management has raised full-year 2026 ARR guidance toward $523-529 million and set a multi-year target of $1 billion in ARR by 2029, while framing 2026 as an investment year to capture AI-driven demand and shifting toward a hybrid pricing model. The stock has been volatile and traded down sharply from prior highs, reflecting broad SaaS multiple compression and investor concern about competition and the pricing transition, even as the underlying operating metrics have kept improving.

The bull case: what would have to be true for $26.00

The most optimistic published target on AVPT is $26.00, +100.5% from the $12.97 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Durable ARR growth toward a $1B target.

AvePoint has posted many consecutive quarters of double-digit organic net-new ARR growth, reaching roughly $435 million of ARR in Q1 2026 (up ~26%). SaaS is the fastest-growing line, up ~35% year over year, and now the majority of revenue. Management's stated goal of $1 billion in ARR by 2029 implies sustained mid-20s percent compounding, which is the central bull-case metric investors watch.

2. 'Trust layer for AI' positioning.

As enterprises deploy Microsoft Copilot and other AI tools on top of their existing data, permissions, sensitivity, and governance become gating problems. AvePoint is marketing its platform as the control and trust layer that makes that data AI-ready, which expands its addressable use cases beyond backup and migration. If AI adoption drives demand for data governance, it could lengthen AvePoint's growth runway.

3. Inflection to profitable growth.

The company reached GAAP profitability in 2025 and lifted non-GAAP operating margin to about 17.5% in Q1 2026 from ~14.4% a year earlier, while still growing in the mid-20s percent. That combination (the so-called Rule of 40) plus a debt-free balance sheet gives it flexibility to invest, and management has authorized share buybacks alongside the growth investment.

4. Global reach and channel leverage.

AvePoint operates across North America, EMEA, and Asia Pacific and sells both direct and through a large managed-service-provider and reseller channel, which broadens its reach into small and mid-sized businesses. Net retention around 111% shows existing customers expanding their spend, and multi-cloud coverage (Microsoft, Google, Salesforce, Box, and others) reduces reliance on any single platform vendor.

The bear case: what would have to be true for $12.00

The most pessimistic published target is $12.00, -7.5% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks AvePoint is worth if the risks below bite instead of the drivers above.

AvePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into. The competitive field is crowded, spanning data-protection vendors (Veeam, Druva, Commvault, Acronis), SaaS-management and governance tools (BetterCloud, Torii, Egnyte), and newer AI-native entrants, which pressures pricing and differentiation. The shift to a hybrid pricing model and the decision to treat 2026 as an investment year add execution and margin-timing risk, and foreign-exchange swings affect a company with large international revenue. As a mid-cap SaaS stock the shares are volatile and sensitive to software multiple compression; the market cap has fallen sharply from prior highs despite improving fundamentals, and a slowdown in ARR growth or enterprise IT budgets would weigh further.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding AVPT already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on AVPT

13 analysts cover AVPT, with an average target of $16.20 (+24.9% against $12.97) and a split of 10 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the AVPT forecast and price target page.

How is AVPT valued? (as of MAY 2026)

Price
$12.97
Market cap
$2.75B
P/E (TTM)
64.85
Forward P/E
26.07
Price / book
6.26
Beta
1.15
52-week range
$8.84 to $19.95

Snapshot for AVPT as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$425 million
  • Q1 2026 Revenue: ~$117 million (up ~26% YoY)
  • Annual Recurring Revenue (ARR): ~$435 million (up ~26% YoY)
  • SaaS Revenue Growth (Q1 2026): ~35% YoY
  • Net Retention Rate: ~111%
  • Non-GAAP Operating Margin (Q1 2026): ~17.5%
  • FY2026 ARR Guidance: ~$523-529 million
  • Market Capitalization: ~$2.5 billion (mid-2026)

AvePoint trades as a growth-oriented SaaS stock, so investors tend to value it on revenue and ARR multiples and the durability of that growth rather than on trailing earnings alone. The company reached GAAP profitability in 2025 and is debt-free with a solid cash position, but the shares have fallen well off prior highs on broad software multiple compression. Management has set a multi-year goal of $1 billion in ARR by 2029.

How do you decide if AVPT is a buy?

Rather than asking whether AVPT is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold AVPT indirectly through an index or sector ETF before adding more.

What would change your mind on AVPT

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Durable ARR growth toward a $1B target stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: avePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the AVPT stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AVPT against your real portfolio and see your actual exposure before deciding.

Investing in AvePoint with AI

Connect the broker you already use and ask Walnut's AI how AVPT fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is AVPT a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Durable ARR growth toward a $1B target, with revenue (ttm) at ~$425 million. The bear case rests on avePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into. Analysts covering it are spread from $12.00 to $26.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell AVPT?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. AvePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $12.00, -7.5% from the $12.97 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for AVPT?

+

Durable ARR growth toward a $1B target. AvePoint has posted many consecutive quarters of double-digit organic net-new ARR growth, reaching roughly $435 million of ARR in Q1 2026 (up ~26%). The most optimistic analyst target on AVPT is $26.00, +100.5% from the $12.97 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for AVPT?

+

AvePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into. The competitive field is crowded, spanning data-protection vendors (Veeam, Druva, Commvault, Acronis), SaaS-management and governance tools (BetterCloud, Torii, Egnyte), and newer AI-native entrants, which pressures pricing and differentiation. The shift to a hybrid pricing model and the decision to treat 2026 as an investment year add execution and margin-timing risk, and foreign-exchange swings affect a company with large international revenue. As a mid-cap SaaS stock the shares are volatile and sensitive to software multiple compression; the market cap has fallen sharply from prior highs despite improving fundamentals, and a slowdown in ARR growth or enterprise IT budgets would weigh further. The most pessimistic published target is $12.00, -7.5% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does AvePoint do?

+

AvePoint, Inc.

What would have to change for AVPT to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Durable ARR growth toward a $1B target) stalling in the reported numbers rather than in the narrative, the risk above (avePoint is heavily tied to the Microsoft 365 ecosystem, so changes to Microsoft's own native backup, governance, or security features could compress the space AvePoint sells into) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does AvePoint do?

+

AvePoint sells cloud-native software that helps organizations back up, migrate, secure, and govern their data across SaaS platforms like Microsoft 365, Google Workspace, and Salesforce. It is increasingly positioned as a governance and trust layer that makes enterprise data ready for AI tools like Microsoft Copilot.

Is AvePoint profitable?

+

AvePoint reached GAAP profitability in 2025 and reported positive GAAP operating income and net income in Q1 2026, with a non-GAAP operating margin of about 17.5%. It also carries a debt-free balance sheet with a meaningful cash position.

How fast is AvePoint growing?

+

In Q1 2026 revenue grew about 26% year over year to roughly $117 million, SaaS revenue grew about 35%, and annual recurring revenue reached roughly $435 million, up about 26%. Management targets $1 billion in ARR by 2029.

Walnut is informational, not investment advice, and gives no verdict on AVPT. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Related stocks

    Is AVPT a Buy or a Sell? The Bull and Bear Case (2026), Walnut